NeurogesX’s Qutenza Potential For Successful Committee Review Hinges On Post Hoc Efficacy Analyses
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA looks askance at the sponsor’s post hoc analyses showing efficacy for its pain patch (capsaicin 8%) for HIV-associated neuropathic pain 30 minutes after application.